
Sign up to save your podcasts
Or


In this week's podcast, Neurology Today's editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.
By American Academy of Neurology4.7
1919 ratings
In this week's podcast, Neurology Today's editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.

138 Listeners

323 Listeners

498 Listeners

297 Listeners

46 Listeners

13 Listeners

191 Listeners

95 Listeners

515 Listeners

137 Listeners

369 Listeners

190 Listeners

375 Listeners

6 Listeners

83 Listeners